During its conference call this afternoon, Karyopharm Therapeutics (KPTI+37.3%) stated that the wholesale (WAC) price of XPOVIO (selinexor) will be $22K per month.
The multiple myeloma med will be distributed through specialty pharmacies, including units of AmerisourceBergen and McKesson.
The company’s marketing application in Europe is currently under EMA review. Management expects conditional approval by year-end.
Applications in diffuse large B-cell lymphoma are next up.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.